Abstract:Protein kinase CK2 is frequently up-regulated in human cancers, although the mechanism of CK2 activation in cancer remains unknown. In this study, we investigated the role of the CK2a intronless gene (CSNK2A1P, a presumed CK2a pseudogene) in the pathogenesis of human cancers. We found evidence of amplification and over-expression of the CSNK2A1P gene in nonsmall cell lung cancer and leukemia cell lines and 25% of the lung cancer tissues studied. The mRNA expression levels correlated with the copy numbers of the CSNK2A1P gene. We also identified a novel polymorphic variant (398T/C, I133T) of the CSNK2A1P gene and showed that the 398T allele is selectively amplified over the 398C allele in 101 non-small cell lung cancer tissue samples compared to those in 48 normal controls (p = 0.013,0.05). We show for the first time CSNK2A1P protein expression in transfected human embryonic kidney 293T and mouse embryonic fibroblast NIH-3T3 cell lines. Both alleles are transforming in these cell lines, and the 398T allele appears to be more transforming than the 398C allele. Moreover, the 398T allele degrades PML tumor suppressor protein more efficiently than the 398C allele and shows a relatively stronger binding to PML. Knockdown of the CSNK2A1P gene expression with specific siRNA increased the PML protein level in lung cancer cells. We report, for the first time, that the CSNK2A1P gene is a functional proto-oncogene in human cancers and its functional polymorphism appears to degrade PML differentially in cancer cells. These results are consistent with an important role for the 398T allele of the CSNK2A1P in human lung cancer susceptibility. Citation: Hung M-S, Lin Y-C, Mao J-H, Kim I-J, Xu Z, et al. (2010) Functional Polymorphism of the CK2a Intronless Gene Plays Oncogenic Roles in Lung Cancer. PLoS ONE 5(7): e11418. doi:10.1371/journal.pone.0011418 Editor: Chun-Ming Wong, University of Hong Kong, Hong Kong Received December 17, 2009; Accepted June 5, 2010; Published July 2, 2010 Copyright: 2010 Hung et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was partially supported by the National Institutes of Health (093708-01A3) and the Larry Hall and Zygielbaum Memorial Trust, and the Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: jablonsd@surgery.ucsf.edu (DMJ); Liang.You@ucsfmedctr.org (LY) . These authors contributed equally to this work.

Title Functional polymorphism of the CK 2 α intronless gene plays oncogenic roles in lung cancer

Deregulation of Casein Kinase-2 in Non-Small-cell Lung Cancer: A Subunit-Specific Analysis

Genetic variants cis -regulating Xrn2 expression contribute to the risk of spontaneous lung tumor

On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach

Functional Regulatory Variants of Mcl1 Contribute to Enhanced Promoter Activity and Reduced Risk of Lung Cancer in Nonsmokers: Implications for Context-Dependent Phenotype of an Antiapoptotic and Antiproliferative Gene in Solid Tumor

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma

Potentially Functional Polymorphisms in Cell Cycle Genes and the Survival of Non-Small Cell Lung Cancer in a Chinese Population

A Functional Polymorphism in Accessible Chromatin Region Confers Risk of Non-Small Cell Lung Cancer in Chinese Population

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

The Mkk7 P.Glu116lys Rare Variant Serves As A Predictor For Lung Cancer Risk And Prognosis In Chinese

C10ORF97 is a Novel Tumor-Suppressor Gene of Non-Small-cell Lung Cancer and a Functional Variant of This Gene Increases the Risk of Non-Small-cell Lung Cancer

Tumor MK2 Transcript Levels Are Associated with Improved Response to Chemotherapy and Patient Survival in Non-Small Cell Lung Cancer.

Abstract 4299: A lineage-specific role of oncogenic protein kinase Cι in lung adenocarcinoma

Abstract LB300: RNA splicing variants of the novel long non-coding RNA, CyKILR, exhibit distinct possess divergent biological functions in lung cancer

A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer

Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung Cancer

Abstract 3105: Orphan nuclear receptor NR4A2 exhibits oncogenic activity in lung cancer cells.

Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

Abstract 348: LKB1 Deficiency Confers Lung Adenocarcinoma Phenotypic Plasticity with Squamous Transdifferentiation Potential.

Expression of Two Transcriptional Splice Variants CK1αtLS and CK1αS of Human CSNK1A1 Gene in Cell Lines

LKB1 Modulates Lung Cancer Differentiation and Metastasis.